Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study

NCT ID: NCT06892080

Last Updated: 2025-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-01

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is a knowledge gap about the influence of the menstrual cycle on bladder function in women with spinal cord injury. So far, studies regarding urinary incontinence have primarily focused on women after menopause. It has become clear that a lack of the sex hormone estrogen, which occurs after menopause, can lead to urinary incontinence. During the course of the menstrual cycle, women also experience fluctuations in their sex hormones, particularly estrogen. The estrogen level is highest before ovulation and decreases afterwards. The investigators aim to explore whether this drop in hormone levels could lead to more frequent urinary incontinence during this phase. In order to offer the patients optimal treatment for urinary incontinence, it is important to understand the potential causes behind it. Participants will document their menstrual cycles and episodes of urinary incontinences over three menstrual cycles using a diary, and urine tests. This research project is a pilot study and is being conducted by Swiss Paraplegic Research at the Swiss Paraplegic Centre. The investigators are recruiting 12 participants who experience incontinence at least once a month and 12 participants who experience incontinence less frequently or not at all.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injury Urinary Incontinence Menstrual Cycle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Premenopausal women with spinal cord injury and urinary incontinence

No interventions assigned to this group

Premenopausal women with spinal cord injury without urinary incontinence

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women
* age ≥ 18 years
* chronic neurogenic bladder dysfunction due to acquired spinal cord injury
* regular menstrual cycle (26-30 days/cycle)
* written consent given
* UI group only: UI at least once per month

Exclusion Criteria

* Detrusor overactivity in storage phase above 15cmH20
* Oligomenorrhea or amenorrhea (infrequent or absent menstrual periods)
* Hormonal intake/contraception
* Intake of androgens
* Intake of drugs which interfere with female sex hormones significantly
* Individuals who underwent sex reassignment surgery
* Pregnant or breastfeeding women
* Women who are trying to conceive
* Gynaecological carcinoma
* Endometriosis
* Ovariectomy
* Current pelvic floor physiotherapy
* Reconstructive surgery of bladder
* Local irritation of the bladder, such as bladder tumour, bladder stones, acute urinary tract infection at study start
* Inability to follow study procedures (cognitive or language barriers)
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss Paraplegic Research, Nottwil

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Swiss Paraplegic Center

Nottwil, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jörg Krebs, Dr. med. vet. / PhD

Role: CONTACT

+41 41 939 59 46

Jürgen Pannek, Prof. Dr. med.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jürgen Pannek, Prof

Role: primary

+41 41 939 59 22

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.